Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Pupil Dilation in Patients Taking Alpha-Blockers for Potential Treatment of Intraoperative Floppy Iris Syndrome

NCT03760185 is registered in ClinicalTrials.gov with Denver Health and Hospital Authority as lead sponsor.

NCT NCT03760185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03760185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Pupil Dilation in Patients Taking Alpha-Blockers for Potential Treatment of Intraoperative Floppy Iris Syndrome
Lead sponsor
Denver Health and Hospital Authority
Phase
Phase 2
Overall status
Completed
Start date
January 4, 2019
Completion date
September 25, 2020
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraoperative floppy iris syndrome